In 2014, the then government commissioned the Accelerated Access Review (AAR), to identify how to fast-track patients’ access to innovative drugs, devices and diagnostics, streamlining the development of new treatments. The AAR’s recommendations were published in 2016, and comprise accelerated pathways for innovative products, improved scanning, incentives for innovation and coordinating national bodies. Current medical innovations are providing hundreds of patients with surgeries for cerebral palsy and pancreatitis, new drugs for haemophilia and stroke-reducing heath implants.
With this policy, the government promised to implement the recommendations of the AAR to speed up advancements in healthcare whilst ensuring value for money.
In November 2017, the government issued a statement detailing how it would implement the recommendations of the AAR. The plans included introducing an Accelerated Access Collaborative (AAC), providing £86 million of funding to support innovators and the health service, and improving the commercial capacity and capability of NHS England. The AAC held its first meeting in January 2018, and it is currently working towards introducing accelerated pathways for innovative treatments.
With the AAC operational, it is fair to say that this policy is ‘in progress’. It will be updated to ‘done’ when there is evidence of significant progress towards implementing all the recommendations of the review. We’ll be monitoring developments so follow this policy to stay up to date.
Read more – accelerate your access to the facts!
- Making sure patients and the NHS benefit from medical innovation – Gov.uk
- Accelerated Access Review: final report – Gov.uk
- Thousands of patients to benefit from innovative new treatments on the NHS – NHS England
- Accelerated access review: government response – Gov.uk
- Accelerated Access Collaborative (AAC) – National Institute for Clinical Excellence
- Accelerated Access Collaborative:Written question – HL6697 – Parliament.uk
- Making decisions about which new treatments to fund – NHS England
- Adoption and spread of innovation in the NHS – The King’s Fund
- What difference will the Accelerated Access Review make for cancer patients? – Institute of Cancer Research
- Integrating innovation into healthcare – Forbes